Carlo Cattaneo

Carlo Cattaneo has extensive work experience in the medical and clinical research field. Carlo has held various roles with different companies over the years. Carlo's most recent position was as the Global Head of Medical Affairs CNS at Zambon, where they led a team and was responsible for launching medications for Parkinson's disease and ALS in Europe, South Ameria, and China. Prior to this, they worked as the Corporate Medical Manager CNS at Zambon, overseeing the CNS therapeutic area and coordinating with international partners. Carlo has also held roles as a Clinical Research Leader at CROMSOURCE, a Clinical Team Manager at CROSS RESEARCH SA, and a Clinical Development Manager at Brane Discovery SrL and Newron Pharmaceuticals SpA. Carlo began their career as a Medical Advisor CNS at SmithKline Beecham and previously worked as a CRA at AstraZeneca and a Clinical Researcher at Instrumentation Laboratory.

Carlo Cattaneo completed their Doctor of Biological Sciences (DBSc) degree from Universita' Studi Milano from 1979 to 1984. Prior to that, they attended Liceo Ginnasio G. Parini via Goito Milano from 1974 to 1979.